Kodiak Sciences Inc. (KOD)财务
NASDAQ · Healthcare · Biotechnology · 员工141人 · CEO Victor Perlroth
- 股价
- $99.18 -1.22%
- 市值
- $62.3亿
- 企业价值
- $62亿
- 最近财报
- Q2 '26 2026-08-13提交
- 下次财报
- 2026-11-12 EPS预期 -$1.06
营收(TTM)$0– 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)–– 对比去年同期营业利润 -$2.46亿
净利润(TTM)-$2.42亿-21.1% 对比去年同期税后,含营业外收益
自由现金流(TTM)-$1.6亿-38.2% 对比去年同期资本支出 $140万
稀释EPS(TTM)-$4.19-10.3% 对比去年同期最近4个季度之和
净现金$3020万-22.5% 对比去年同期现金 + 短期投资 - 债务
估值与关键数据
- 市值
- $62.3亿 EV $62亿
- 营收
- $0 过去12个月
- 营收增速
- – FY2026年一致预期
- 净利润率
- – 净利润 / 营收,TTM
- P/E
- -23.7× 预期 -24.3×(FY2026)
- P/S
- 0.0× 股价 / 营收,TTM
- EV / EBITDA
- -29.0× TTM
- 自由现金流
- -$1.6亿 过去12个月
- 净利润
- -$2.42亿 过去12个月
- 营收预期
- $1130万 FY2026年一致预期
- 盈利
- 2026-11-12
- 股息
- – 无股息
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 最近财报(2026-08-12):营收无,EPS 低于预期9.8%营收–,预期–(–);EPS -$1.05,预期-$0.96(-9.8%)。
- 稀释股数一年内增加18.7%Q2 '26稀释股数6260万,一年前为5280万。
- 净现金 $3020万现金 + 短期投资 $1.26亿,含租赁债务 $9570万;一年前净现金 $3900万。
上一季度:Q2 '26
截至2026-06-30的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q2 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $0 | $0 | – |
| 营业利润 | -$6680万 | -$5550万 | -20.4% |
| 净利润 | -$6560万 | -$5430万 | -20.9% |
| 稀释EPS | -$1.05 | -$1.03 | -1.9% |
| 经营现金流 | -$4620万 | -$3470万 | -33.4% |
| 资本支出 | $35.2万 | $13.3万 | +164.7% |
| 自由现金流 | -$4660万 | -$3480万 | -33.9% |
| R&D | $5610万 | $4280万 | +31.2% |
| 股权激励费用 | $1160万 | $1560万 | -25.8% |
实际 vs 一致预期
2026-08-12| 实际 | 一致预期 | 对比预期 | |
|---|---|---|---|
| EPS(一致预期口径) | -$1.05 | -$0.96 | -9.8% |
来自2026-08-12发布的Q2 '26财报：营收及分析师预期口径的EPS（通常为调整后），可能与上方报表中的EPS不同。
EPS与一致预期
最近8次财报营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- -$1.59亿
- 资本支出
- -$140万
- 股票回购
- $0
- 股息
- $0
- 收购
- $0
- 债务净发行
- $0
- 股权激励费用
- $6510万
- 自由现金流
- -$1.6亿
- 股东回报 / FCF
- 0.0%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | -23.7× | – | – |
| EV / EBITDA | -29.0× | – | – |
| EV / 营收 | 0.0× | – | – |
| 股价 / FCF | -39.0× | – | – |
| 股价 / 净资产 | 101.7× | 3.1× | 0.6× – 9.5× |
| FCF收益率 | -2.6% | -50.0% | -122.8% – -9.2% |
| 投入资本回报率 | -115.2% | -56.1% | -73.7% – -31.7% |
| 净资产收益率 | -273.2% | -95.6% | -146.1% – -40.3% |
分析师
一致目标价 $104.40 (+5.3%)
区间 $61.00 – $126.00 · 评级 Buy
强烈买入0
买入14
持有4
卖出1
强烈卖出0
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $1130万 | – | -$4.08 | +5.6% | -24.3× | 4 |
| FY2027 | $4910万 | +334.1% | -$3.85 | +5.6% | -25.8× | 3 |
| FY2028 | $3.75亿 | +663.8% | -$0.51 | +86.8% | -194.9× | 5 |
| FY2029 | $10.2亿 | +173.0% | $5.82 | +1,243.6% | 17.0× | 1 |
| FY2030 | $16亿 | +55.9% | $9.63 | +65.5% | 10.3× | 1 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
Kodiak Sciences Inc.在近期10-Q / 10-K文件中标记的全部145项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $1260万 | $506万 | +149.9% | $1290万 | $392万 | +228.6% |
| Accretion (Amortization) of Discounts and Premiums, Investments | – | – | – | $0 | $0 | – |
| Accrued Liabilities, Current | $3030万 | $1470万 | +106.7% | $2060万 | $1100万 | +86.8% |
| Accrued Professional Fees, Current | $53.7万 | – | – | $3.9万2022-12-31 | $17.6万 | -77.8% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $5950万2025-12-31 | $4130万 | +44.1% | $5950万 | $4130万 | +44.1% |
| Additional Paid in Capital, Common Stock | $17.4亿 | $15.1亿 | +15.4% | $17.2亿 | $14.8亿 | +16.0% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 2170万 | 2010万 | +7.8% | 2240万 | 2000万 | +11.7% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $1160万 | $1560万 | -25.8% | $5890万 | $6020万 | -2.2% |
| Assets | $2.57亿 | $2.57亿 | 0.0% | $3.52亿 | $3.36亿 | +4.8% |
| Assets, Current | $1.31亿 | $1.08亿 | +21.7% | $2.15亿 | $1.72亿 | +24.9% |
| Cash and Cash Equivalents, at Carrying Value | $1.26亿 | $1.04亿 | +20.9% | $2.1亿 | $1.68亿 | +24.9% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | $1.32亿 | $1.1亿 | +19.7% | $2.16亿 | $1.74亿 | +24.0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | -$4360万 | -$3470万 | -25.8% | $4180万 | -$1.18亿 | +135.5% |
| Common Stock, Capital Shares Reserved for Future Issuance | 2330万2025-12-31 | 2220万 | +4.9% | 2330万 | 2220万 | +4.9% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 4.9亿 | 4.9亿 | 0.0% | 4.9亿 | 4.9亿 | 0.0% |
| Common Stock, Shares, Issued | 6280万 | 5280万 | +18.9% | 6180万 | 5270万 | +17.1% |
| Common Stock, Shares, Outstanding | 6280万 | 5280万 | +18.9% | 6180万 | 5270万 | +17.1% |
| Common Stock, Value, Issued | $6000 | $5000 | +20.0% | $6000 | $5000 | +20.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | – | – | – | -$2.3亿 | -$1.76亿 | -30.5% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $5.2万 | $2万 | +160.0% |
| Debt Securities, Available-for-sale, Allowance for Credit Loss | $02025-12-31 | $0 | – | $0 | $0 | – |
| Deferred Tax Assets, Goodwill and Intangible Assets | $1190万2025-12-31 | $1190万 | -0.1% | $1190万 | $1190万 | -0.1% |
| Deferred Tax Assets, Gross | $2.96亿2025-12-31 | $2.58亿 | +15.0% | $2.96亿 | $2.58亿 | +15.0% |
| Deferred Tax Assets, in Process Research and Development | $2130万2025-12-31 | $2370万 | -10.0% | $2130万 | $2370万 | -10.0% |
| Deferred Tax Assets, Net | $02025-12-31 | $0 | – | $0 | $0 | – |
| Deferred Tax Assets, Net of Valuation Allowance | $800万2025-12-31 | $1030万 | -22.2% | $800万 | $1030万 | -22.2% |
| Deferred Tax Assets, Operating Loss Carryforwards | $1.8亿2025-12-31 | $1.47亿 | +22.7% | $1.8亿 | $1.47亿 | +22.7% |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | $3720万2025-12-31 | $3260万 | +13.9% | $3720万 | $3260万 | +13.9% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $3270万2025-12-31 | $2790万 | +17.2% | $3270万 | $2790万 | +17.2% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | $157万2025-12-31 | $109万 | +44.6% | $157万 | $109万 | +44.6% |
| Deferred Tax Assets, Valuation Allowance | $2.88亿2025-12-31 | $2.47亿 | +16.5% | $2.88亿 | $2.47亿 | +16.5% |
| Deferred Tax Liabilities, Gross | $800万2025-12-31 | $1030万 | -22.2% | $800万 | $1030万 | -22.2% |
| Deferred Tax Liabilities, Property, Plant and Equipment | $111万2025-12-31 | $146万 | -24.2% | $111万 | $146万 | -24.2% |
| Defined Contribution Plan, Cost | – | – | – | $100万 | $90万 | +11.1% |
| Defined Contribution Plan, Employer Matching Contribution, Percent of Match | – | – | – | 100.0% | 100.0% | 0.0% |
| Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount | – | – | – | $1030万 | $1030万 | 0.0% |
| Depreciation | $411万 | $459万 | -10.5% | $1830万 | $1870万 | -2.0% |
| Earnings Per Share, Basic | -$1.05 | -$1.03 | -1.9% | -$4.32 | -$3.35 | -29.0% |
| Earnings Per Share, Diluted | -$1.05 | -$1.03 | -1.9% | -$4.32 | -$3.35 | -29.0% |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | – | – | – | -$4830万 | -$3700万 | -30.5% |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | – | – | – | 21.0% | 21.0% | 0.0% |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | – | – | – | $3000万 | $1820万 | +65.1% |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | – | – | – | -13.0% | -10.3% | -26.2% |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | – | – | – | $740万 | $526万 | +40.8% |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | – | – | – | -3.2% | -3.0% | -6.7% |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | – | – | – | $13.7万 | $9.4万 | +45.7% |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | – | – | – | -0.1% | -0.1% | 0.0% |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | – | – | – | $438万 | $898万 | -51.2% |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | – | – | – | -1.9% | -5.1% | +62.7% |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | – | – | – | $12万 | $2.8万 | +328.6% |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | – | – | – | -0.1% | 0.0% | – |
| Effective Income Tax Rate Reconciliation, Percent | – | – | – | 0.0% | 0.0% | – |
| Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | – | – | – | -$324万 | -$231万 | -40.2% |
| Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | – | – | – | 1.4% | 1.3% | +7.7% |
| Employee-related Liabilities, Current | $496万 | $400万 | +23.9% | $777万 | $527万 | +47.6% |
| Foreign Currency Transaction Gain (Loss), Realized | – | – | – | -$100万 | $30万 | -433.3% |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $02025-12-31 | $0 | – | $0 | -$35.5万 | +100.0% |
| Gain (Loss) on Disposition of Assets | $0 | $0 | – | – | – | – |
| General and Administrative Expense | $1080万 | $1280万 | -15.6% | $5200万 | $6080万 | -14.4% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
数据截至 2026-11-02